Penn Medicine Provider
Dermatology
Jennifer Villasenor-Park, MD, PhD
4.9
(1621)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Bucks County
View 1 additional location
Schedule onlineCall 215-504-7700

About me

  • Associate Professor of Clinical Dermatology

Education and training

  • Medical School: Harvard University
  • Residency: University of Massachusetts Medical Center
  • Residency: UPMC Presbyterian

What my patients think about me

Average Rating
4.9

1621 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

August 2025
5.0
5.0
very knowledgeable provider
August 2025
5.0
5.0
excellent practitioner.
August 2025
5.0
5.0
personal care
August 2025
5.0
5.0
answered questions

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Villasenor-Park is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome , J Am Acad Dermatol, 92(3): 2025,634-36

Villasenor-Park J, Chung J, Kim EJ Cutaneous B-Cell Lymphomas , Hematol Oncol Clin North Am, 38(5): 2024,1111-31

Himeles JR, Holton J, Vittorio C, Rook AH, Haun P, Villasenor-Park J, Samimi S, Kim EJ Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma , J Am Acad Dermatol, 88(3): 2023,680-83

Villasenor-Park J, Kim E Chapter 113: Sezary Syndrome in "Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment , McGraw-Hill LLC: 2023,502

Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS Usage and safety of topical tacrolimus in patients with mycosis fungoides , Clin Exp Dermatol , 47(6): 2022,1200-01

Xu Z, Margolskee E, Villasenor-Park J, Rubin AI, Khurana MC A healthy 16-year-old boy presenting with multifocal asymptomatic subcutaneous nodules , Pediatr Dermatol, 39(1): 2022,E8-E10

Lewis DJ, Haun PL, Samimi SS, Vittorio CC, Villasenor-Park J, Barta SK, Landsburg DJ, Svoboda J, Nasta SD, Schuster SJ, Rook AH, Kim EJ Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome , JAMA Dermatol, 157(3): 2021,317-21

Durgin JS, Jariwala NN, Wysocka M, Zhang KK, Maity A, Benoit B, Plastaras JP, Lewis DJ, Rosenthal JM, Teague JE, Berg S, Del Guzzo C, Kim EJ, Vittorio C, Huan PL, Samimi SS, Villasenor-Park J, Inverso J, Clark RA, Rook AH Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis , JAMA Dermatol, 157(1): 2021,90-95

Villasenor-Park J Dermatologic Surgery in Pregnancy in "Cutaneous Disorders of Pregnancy" , Springer Nature Link: 2020,113-121

Villasenor-Park J Skin Cancer in Pregnancy in "Cutaneous Disorders of Pregnancy" , Springer Nature Link: 2020,89-111